Tuesday, 6 July 2021

Torrent Pharmaceutical gets exemption of DPCO for their formulation Tapentadol Nasal Spray

Torrent Pharmaceutical gets exemption of DPCO for their formulation Tapentadol Nasal Spray
Torrent Pharmaceutical gets exemption of DPCO for their formulation Tapentadol Nasal Spray

National Pharmaceutical Pricing Authority (NPPA) grants exemption from Drugs Price Control Order (DPCO) 2013 to Torrent Pharmaceuticals for their formulation of Tapentadol Nasal Spray.

admin Tue, 07/06/2021 - 14:47

source https://www.pharmatutor.org/pharma-news/2021/torrent-pharmaceutical-gets-exemption-of-dpco-for-their-formulation-tapentadol-nasal-spray

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...